Blood News and Research

RSS

Bionime, GE enter licensing agreement to provide diabetes solutions

GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.

18 Jan 2012

Vitamin D supplements can fight against age-related macular degeneration

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found that vitamin D reduces the effects of ageing in mouse eyes and improves the vision of older mice significantly. The researchers hope that this might mean that vitamin D supplements could provide a simple and effective way to combat age-related eye diseases, such as macular degeneration (AMD), in people.

17 Jan 2012

Regorafenib lengthens lives of patients with metastatic colorectal cancer

An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.

17 Jan 2012

Vitamin D provides no relief from chronic obstructive pulmonary disease

Earlier studies have suggested that up to three quarters of people with severe chronic obstructive pulmonary disease, or COPD, are deficient in the vitamin. So it was thought that giving them extra vitamin D might help prevent exacerbations in symptoms or trips to the hospital because of shortness of breath or mucus in the airways. Belgian researchers have refuted this claim.

17 Jan 2012

Gastric bypass superior to lap banding finds study

A new study evaluates the best option in terms of weight loss surgery for those who need it. Researchers found gastric bypass patients lose more weight than gastric banding patients and keep it off longer. Even though banding is a simpler operation, nearly half of those patients were still obese after six years.

17 Jan 2012

Nurse donates kidney to patient

A nurse offered to donate her own kidney to a 23-year-old patient. Allison Batson spent two years on the transplant floor of Emory University Hospital before her encounter with Clay Taber, a recent Auburn University graduate who fell sick one day after his 22nd birthday. He was diagnosed with kidney failure. The Auburn University graduate was diagnosed with Goodpasture's syndrome, a rare autoimmune disease that can result in severe damage to the kidneys and lungs.

17 Jan 2012

Neutracorp finalizes new proprietary weight-loss formula

Neutracorp announced today that it has finalized its new proprietary weight-loss formula—including an all-natural Bio-Energy Boost that could help make losing weight easier and faster than ever before.

17 Jan 2012

Hot yoga practicing tips

Yoga is one of the hottest fitness trends and a style known as "hot yoga" is gaining in popularity. Hot yoga refers to yoga practiced in a heated environment, with the room temperature generally reaching 90 to 105 degrees. The theory behind it is that hot yoga helps the body to sweat out toxins while allowing the practitioner to safely achieve deeper poses. Bikram is a common form of hot yoga.

17 Jan 2012

Older adults with dementia can benefit from exergames

Virtual reality-enhanced exercise, or "exergames," combining physical exercise with computer-simulated environments and interactive videogame features, can yield a greater cognitive benefit for older adults than traditional exercise alone, according to a new study published in the February issue of the American Journal of Preventive Medicine.

17 Jan 2012

Angioplasty improves quality of life in MS patients

Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps - in some cases dramatically, such as allowing them to walk without a cane. Patients with less severe MS also reported additional quality of life improvements, such as being able to talk more clearly, after having treatment to open blocked blood vessels in the chest and neck, according to research being presented at the 24th annual International Symposium on Endovascular Therapy.

17 Jan 2012

New way to block HCV infection in the liver

Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.

17 Jan 2012

Positive outcomes from Boston Scientific's Epic Stent trial on iliac artery disease

Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.

16 Jan 2012

Man gets new windpipe with stem cell therapy

Christopher Lyles, 30, of Abingdon, Md, became the first American to undergo an experimental procedure, involving stem cells to treat his trachea cancer. A trachea or windpipe connects the nose and mouth to the lungs, serving a crucial function for life.

16 Jan 2012

Hormone that burns energy discovered

Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.

16 Jan 2012

New research reveals legacy of lead from old inner city roads a major source of airborne contamination

An international research study published last week in the journal Atmospheric Environment has found that re-suspended roadside soil dust is a major source of atmospheric lead in old inner city areas.

15 Jan 2012

Multiple medicines use very common: New snapshot of over-50s' medicine habits

A study by NPS in collaboration with the University of Melbourne —published today in the Medical Journal of Australia — has provided new insights into how people use medicines on a daily basis and highlights that the use of multiple medicines in older Australians is common and more complex than previously thought.

15 Jan 2012

Heavy drinking may reinforce itself by stimulating endorphin release: Study

A new study has shown that drinking alcohol causes a pleasant feeling because it releases endorphins, the brain’s natural opioids. It adds that problem drinkers differ from social drinkers in the way alcohol affects one part of the brain. The report appeared Wednesday in Science Translational Medicine.

15 Jan 2012

Improving obstetric care with solar power

In the National Geographic News blog "Mobile Message," "a series of posts from FrontlineSMS about how mobile phones and appropriate technologies are being used throughout the world to improve, enrich, and empower billions of lives," Laura Stachel, an obstetrician-gynecologist and the co-founder and executive director of WE CARE Solar, writes about the "'Solar Suitcase,' a portable, rugged, complete solar electric kit packed with solar panels, a charge controller, batteries, medical LED lights, phone chargers, headlamps, and a fetal monitor."

13 Jan 2012

Red wine and dark chocolate are the real food of love

Forget the oysters and the champagne this Valentine's Day. If you want to keep your true love's heart beating strong, Susan Ofria, clinical nutrition manager at Gottlieb Memorial Hospital, said the real food of love is dark chocolate and red wine.

13 Jan 2012

Smart injectable nanotherapeutics could improve treatment for Type I diabetes

A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.

13 Jan 2012